Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SDZ-62-434 is a platelet-activating factor inhibitor with antitumor activity that inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells for the study of leukemia, human xenograft colorectal cancer, and lung cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 |
Description | SDZ-62-434 is a platelet-activating factor inhibitor with antitumor activity that inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells for the study of leukemia, human xenograft colorectal cancer, and lung cancer. |
Synonyms | SDZ 62 434, SDZ62434 |
Molecular Weight | 416.39 |
Formula | C23H27Cl2N3 |
CAS No. | 115621-95-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SDZ-62-434 115621-95-9 Others Platelet aggregation SDZ-62434 SDZ 62 434 SDZ62434 SDZ 62434 inhibitor inhibit